-+ 0.00%
-+ 0.00%
-+ 0.00%

VIR BIOTECHNOLOGY - PHASE 3 TRIALS FOR VIR-5500 ANTICIPATED TO BEGIN IN 2027

Reuters·10/08/2026 12:30:00

Please log in to view news